Literature DB >> 2112058

Transplacental transfer of aflatoxin in humans.

D W Denning1, R Allen, A P Wilkinson, M R Morgan.   

Abstract

This study quantified aflatoxin (AFB1, AFG1 and AFQ1) by enzyme-linked immunosorbent assay in human cord sera obtained at birth and in serum obtained immediately after birth from the mother. The subjects of the study were residents of Songkhla, Thailand. Of the 35 samples of cord sera, 17 (48%) contained aflatoxin in concentrations from 0.064 to 13.6, mean 3.1 nmol/ml. By comparison only two (6%) of 35 maternal sera contained aflatoxin (mean 0.62 nmol/ml). These results demonstrate transplacental transfer and concentration of aflatoxin by the feto-placental unit which may be of biological importance. Aflatoxins are mutagenic, carcinogenic and teratogenic and cause immunosuppression in animals. The implications of these findings are potentially profound and deserve further study.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112058     DOI: 10.1093/carcin/11.6.1033

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  14 in total

1.  Immunosuppressive effects of aflatoxin in growing rats.

Authors:  S Raisuddin; K P Singh; S I Zaidi; B N Paul; P K Ray
Journal:  Mycopathologia       Date:  1993-12       Impact factor: 2.574

2.  Socio-demographic determinants of aflatoxin B1-lysine adduct levels among pregnant women in Kumasi, Ghana.

Authors:  F M B Shuaib; P E Jolly; J E Ehiri; W O Ellis; N J Yatich; E Funkhouser; S D Person; J H Williams; G Qian; J-S Wang
Journal:  Ghana Med J       Date:  2012-12

3.  Prenatal exposure of mice to the human liver carcinogen aflatoxin B1 reveals a critical window of susceptibility to genetic change.

Authors:  Supawadee Chawanthayatham; Apinya Thiantanawat; Patricia A Egner; John D Groopman; Gerald N Wogan; Robert G Croy; John M Essigmann
Journal:  Int J Cancer       Date:  2014-08-07       Impact factor: 7.396

4.  Aflatoxin induces depletion of activities of phase I biotransformation enzymes in growing rats.

Authors:  S Raisuddin; D Parmar; S I Zaidi; K P Singh; A S Verma; P K Seth; P K Ray
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Apr-Jun       Impact factor: 2.441

Review 5.  Aflatoxin Exposure and Associated Human Health Effects, a Review of Epidemiological Studies.

Authors:  Yun Yun Gong; Sinead Watson; Michael N Routledge
Journal:  Food Saf (Tokyo)       Date:  2016-03-30

Review 6.  Aflatoxin Exposure During Pregnancy, Maternal Anemia, and Adverse Birth Outcomes.

Authors:  Laura E Smith; Andrew J Prendergast; Paul C Turner; Jean H Humphrey; Rebecca J Stoltzfus
Journal:  Am J Trop Med Hyg       Date:  2017-04       Impact factor: 2.345

7.  Infants' Exposure to Aflatoxin M1 from Mother's Breast Milk in Iran.

Authors:  Sa Ghiasian; Ah Maghsood
Journal:  Iran J Public Health       Date:  2012-03-31       Impact factor: 1.429

8.  Transplacental transfer of genotoxins and transplacental carcinogenesis.

Authors:  H Autrup
Journal:  Environ Health Perspect       Date:  1993-07       Impact factor: 9.031

9.  The Potential Role of Mycotoxins as a Contributor to Stunting in the SHINE Trial.

Authors:  Laura E Smith; Andrew J Prendergast; Paul C Turner; Mduduzi N N Mbuya; Kuda Mutasa; George Kembo; Rebecca J Stoltzfus
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

10.  Editor's Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver.

Authors:  Kanokwan Sriwattanapong; Stephen L Slocum; Supawadee Chawanthayatham; Bogdan I Fedeles; Patricia A Egner; John D Groopman; Jutamaad Satayavivad; Robert G Croy; John M Essigmann
Journal:  Toxicol Sci       Date:  2017-11-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.